Pharmaceutical use of 3-benzylsulfonylpropionitrile
The present invention relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 3-benzylsulfonylpropionitrile, or its pharmaceutically acceptable salts. The present invention also relates to methods of using the compound for treating inflammation or inflammatory-related disorders and pain.
1. A method of treating inflammation and/or pain, comprising the step of:
administering to a subject suffering from inflammation or pain a compound of 3-benzylsulfonylpropionitrile, or a pharmaceutically acceptable salt thereof, in an amount effective to treat inflammation or pain.
2. The method according to claim 1 , wherein said method reduces or alleviates the symptoms of localized manifestations of inflammation characterized by acute or chronic swelling, pain, or redness.
3. The method according to claim 1 , wherein said method treats nociceptive pain.
4. The method according to claim 1 , wherein said compound is administered by local administration or systemic administration.
5. The method according to claim 1 wherein said compound is administered by topical administration.
6. The method according to claim 1 wherein said compound is administered by oral administration.
7. The method according to claim 1 , wherein said inflammation and/or pain is associated with a skeletal or muscular disease or condition selected from the group consisting of: musculoskeletal sprains, musculoskeletal strains, tendonopathy, peripheral radiculopathy, osteoarthritis, degenerative joint disease, juvenile arthritis, gout, ankylosing spondylitis, psoriatic arthritis, system lupus erythematosus, costochondritis, tendonitis, bursitis, temporomandibular joint syndrome, and fibromyalgia.
8. The method according to claim 1 , wherein said inflammation and/or pain is associated with joints, ligaments, tendons, bone, muscles, or fascia.
9. The method according to claim 1 , wherein said inflammation and/or pain is associated with an inflammatory skin disease or disorder of dermatitis or psoriasis.
10. The method according to claim 9 , wherein said dermatitis is atopic dermatitis or contact dermatitis.
11. A method of treating an inflammatory skin disease or disorder, comprising the step of:
administering 3-benzylsulfonylpropionitrile, or a pharmaceutically acceptable salt thereof, to a subject suffering from an inflammatory skin disease or disorder, in an amount effective to reduce or eliminate the symptoms of the inflammatory skin disease or disorder,
wherein the inflammatory skin disease or disorder is dermatitis, psoriasis, acne, or rosacea.
12. The method according to claim 11 , wherein said method treats atopic dermatitis and alleviates one or more symptoms selected from the group consisting of erythema, induration, lichenification, scaling, and oozing and crusting.
13. The method according to claim 11 , wherein said method treats contact dermatitis and alleviates one or more symptoms selected from the group consisting of erythema, edema, lichenification, scaling, fissuring, and micro or macrovesiculation.
14. The method according to claim 11 , wherein said method treats psoriasis and alleviates erythema, scaling, and/or thickness of the psoriasis lesions.
15. The method according to claim 11 , wherein said method treats acne and alleviates one or more lesions selected from the groups consisting of closed comedones, papules, pustules, nodules, and cysts.
16. The method according to claim 11 , wherein said method treats rosacea and alleviates one or more symptoms selected from the group consisting of erythema, telangiectasia, red domed papules and pustules, red gritty eyes, and burning and stinging sensations.